Ποια είναι η τιμή για Probi AB (publ) (PROB)

Η τιμή για Probi AB (publ) (PROB) είναι $38.87

Ποια είναι η κεφαλαιοποίηση αγοράς για Probi AB (publ) (PROB)

Η κεφαλαιοποίηση αγοράς για Probi AB (publ) (PROB) είναι $442.88M

Probi AB (publ) (PROB) Τιμή και Κεφαλαιοποίηση Αγοράς

Probi AB (publ) specializes in the research, development, manufacturing, marketing, and distribution of probiotics for the health, pharmaceutical, and food sectors. The company's scientific endeavors primarily focus on areas such as gastrointestinal, digestive, immune, and bone health, as well as iron absorption, and the specific health requirements of children, women, and seniors. Their product range includes dietary supplements and various food and beverage applications, offered in diverse formats like capsules, tablets (including chewable), spheres, powders, and an array of drinks such as fruit drinks, shots, carbonated beverages, and recovery drinks. Probi's products are sold in approximately 40 countries globally. The company also fosters collaborations, including a partnership with Örebro University for exploring needle-free vaccines and with La Trobe University for a clinical trial assessing the effects of Probi Osteo in Australian women. Established in 1991 and headquartered in Lund, Sweden, Probi AB (publ) operates as a subsidiary of Symrise AG.

Η τιμή για PROB	Το περιουσιακό στοιχείο B	Η κεφαλαιοποίηση αγοράς του B	Αποτελέσματα
$467,505 $442.88M	NVDA	$5.327T	+1,202,661.09%
$407,656 $442.88M	AAPL	$4.645T	+1,048,685.92%
$357,225 $442.88M	GOOG	$4.070T	+918,940.99%
$332,153 $442.88M	MSFT	$3.785T	+854,436.08%
$244,874 $442.88M	AMZN	$2.790T	+629,893.42%

Η τιμή για PROB

Το περιουσιακό στοιχείο B

Η κεφαλαιοποίηση αγοράς του B

Αποτελέσματα

$467,505 $442.88M